Paper33568554
Understanding the Impact of Resistance to Influenza Antivirals.
Holmes EC and 5 others. Clin Microbiol Rev, 2021. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Understanding the Impact of Resistance to Influenza Antivirals. Papers, record 33568554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33568554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Influenza, Human | Major topic |
| Drug Resistance, Viral | |
| Humans |
Source PubMed
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23732307 | Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial. | J Infect Chemother | 2013 | https://conductscience.org/library/papers/23732307 | PubMed |
| 2 | 1576586 | Antiviral therapy: current concepts and practices. | Clin Microbiol Rev | 1992 | https://conductscience.org/library/papers/1576586 | PubMed |
| 3 | 20936975 | Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial. | Clin Infect Dis | 2010 | https://conductscience.org/library/papers/20936975 | PubMed |
| 4 | 32056049 | Influenza and antiviral resistance: an overview. | Eur J Clin Microbiol Infect Dis | 2020 | https://conductscience.org/library/papers/32056049 | PubMed |
| 5 | 32071422 | We shouldn't worry when a virus mutates during disease outbreaks. | Nat Microbiol | 2020 | https://conductscience.org/library/papers/32071422 | PubMed |
| 6 | 19048205 | Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases. | Handb Exp Pharmacol | 2009 | https://conductscience.org/library/papers/19048205 | PubMed |
| 7 | 30184455 | Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. | N Engl J Med | 2018 | https://conductscience.org/library/papers/30184455 | PubMed |
| 8 | 23437766 | Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus. | J Med Chem | 2013 | https://conductscience.org/library/papers/23437766 | PubMed |
| 9 | 25691635 | Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/25691635 | PubMed |
| 10 | 30086337 | Comparison of antiviral resistance across acute and chronic viral infections. | Antiviral Res | 2018 | https://conductscience.org/library/papers/30086337 | PubMed |
| 11 | 20215135 | Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations. | J Antimicrob Chemother | 2010 | https://conductscience.org/library/papers/20215135 | PubMed |
| 12 | 19812437 | Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007. | Antivir Ther | 2009 | https://conductscience.org/library/papers/19812437 | PubMed |
| 13 | 20368393 | Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/20368393 | PubMed |
| 14 | 27178527 | Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. | Trends Mol Med | 2016 | https://conductscience.org/library/papers/27178527 | PubMed |
| 15 | 29265727 | Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study. | Influenza Other Respir Viruses | 2018 | https://conductscience.org/library/papers/29265727 | PubMed |
| 16 | 31538644 | Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes. | Clin Infect Dis | 2020 | https://conductscience.org/library/papers/31538644 | PubMed |
| 17 | 27281742 | Approved Antiviral Drugs over the Past 50 Years. | Clin Microbiol Rev | 2016 | https://conductscience.org/library/papers/27281742 | PubMed |
| 18 | 28694997 | Antiviral drug resistance as an adaptive process. | Virus Evol | 2016 | https://conductscience.org/library/papers/28694997 | PubMed |
| 19 | 22966122 | Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission. | J Infect Dis | 2012 | https://conductscience.org/library/papers/22966122 | PubMed |
| 20 | 29941893 | Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. | Sci Rep | 2018 | https://conductscience.org/library/papers/29941893 | PubMed |
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947434 | Efficacy and safety of Lianhua Qingwen versus oseltamivir in children with influenza: a multicenter, randomized, double-blind, positive parallel-controlled study. | Pharm Biol | 2026 | https://conductscience.org/library/papers/42947434 | PubMed |
| 42851010 | Trends, Gaps, and Challenges in Antiviral Resistance: A Bibliometric Analysis and Narrative Synthesis of Key Viruses, Resistance Mechanisms, and Drivers. | Biomed Res Int | 2026 | https://conductscience.org/library/papers/42851010 | PubMed |
| 42617142 | A bispecific antibody targeting conserved hemagglutinin epitopes confers broad protection against H7 avian influenza and accelerates viral clearance via localized respiratory delivery. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/42617142 | PubMed |
| 42560041 | Detection and characterization of antiviral-resistant viruses during the influenza season of 2024-25. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/42560041 | PubMed |
| 42306964 | Antiviral Resistance in Influenza: Clinical and Public Health Implications. | Influenza Other Respir Viruses | 2026 | https://conductscience.org/library/papers/42306964 | PubMed |
| 42262426 | IgY technology (egg yolk antibodies) in respiratory medicine: applications and future prospects. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42262426 | PubMed |
| 42164493 | Research progress in the inhibitory mechanisms of traditional Chinese medicine therapies against influenza A. | Front Immunol | 2026 | https://conductscience.org/library/papers/42164493 | PubMed |
| 42099460 | A large-scale single-cell transcriptomic atlas indicates the immune panorama of influenza A infection. | Imeta | 2026 | https://conductscience.org/library/papers/42099460 | PubMed |
| 41751469 | Rhus coriaria Linn Extract as a Natural Inhibitor of Influenza A Virus Replication In Vitro. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/41751469 | PubMed |
| 41594075 | Leveraging Different Distance Functions to Predict Antiviral Peptides with Geometric Deep Learning from ESMFold-Predicted Tertiary Structures. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/41594075 | PubMed |
| 41555529 | Emergence of the novel PA-D27G mutation conferring reduced baloxavir susceptibility in influenza A viruses circulating in China, 2018-2025. | Emerg Microbes Infect | 2026 | https://conductscience.org/library/papers/41555529 | PubMed |
| 41105303 | Antiviral strategies against H5N1: current options and emerging therapeutics. | Infection | 2026 | https://conductscience.org/library/papers/41105303 | PubMed |
| 41025086 | Recent advances in avian influenza virus: Molecular pathogenesis, emerging strains, and next-generation therapeutics. | World J Virol | 2025 | https://conductscience.org/library/papers/41025086 | PubMed |
| 40929256 | Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutations. | Sci Adv | 2025 | https://conductscience.org/library/papers/40929256 | PubMed |
| 40883700 | Epidemiological dynamics of influenza B virus across multiple seasons in Kenya and Uganda inferred from sequence data, 2010-2021. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/40883700 | PubMed |
| 40378143 | Fast and flu-rious: How to prevent and treat emerging influenza A viruses. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40378143 | PubMed |
| 40176109 | Neutralizing monoclonal antibodies as effective therapeutics and prophylactics against lethal H10N7 avian influenza infection in a mouse model. | Vet Res | 2025 | https://conductscience.org/library/papers/40176109 | PubMed |
| 40146495 | Identification of Novel Neuraminidase Inhibitors as Potential Anti-Influenza Agents: Virtual Screening, Molecular Docking, in vitro Validation and Molecular Dynamic Simulation Studies. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/40146495 | PubMed |
| 39717708 | A meta-analysis highlights the idiosyncratic nature of tradeoffs in laboratory models of virus evolution. | Virus Evol | 2024 | https://conductscience.org/library/papers/39717708 | PubMed |
| 39458339 | Interplay between Lung Diseases and Viral Infections: A Comprehensive Review. | Microorganisms | 2024 | https://conductscience.org/library/papers/39458339 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33568554
GET https://conductscience.org/api/papers/v1/33568554/references?page=2